PAR DRUGS AND CHEMICALS Financial Statement Analysis
|
||
|
The Revenues of PAR DRUGS AND CHEMICALS have increased by 5.58% YoY .
The Earnings Per Share (EPS) of PAR DRUGS AND CHEMICALS has decreased by -7.89 % YoY. |
||
PAR DRUGS AND CHEMICALS Last 5 Annual Financial Results
[NSE : PAR]
| Standalone | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹101 Cr | ₹96 Cr | ₹96 Cr | ₹75 Cr | ₹61 Cr |
| Expenses | ₹81 Cr | ₹73 Cr | ₹78 Cr | ₹59 Cr | ₹45 Cr |
| Operating Profit (Excl OI) | ₹20 Cr | ₹23 Cr | ₹18 Cr | ₹16 Cr | ₹16 Cr |
| Other Income | ₹2.15 Cr | ₹0.24 Cr | ₹0.24 Cr | ₹0.18 Cr | ₹0.19 Cr |
| Interest | ₹0.08 Cr | ₹0.11 Cr | ₹0.13 Cr | ₹0.45 Cr | ₹0.64 Cr |
| Depreciation | ₹3.65 Cr | ₹3.44 Cr | ₹3.23 Cr | ₹3.28 Cr | ₹2.82 Cr |
| Profit Before Tax | ₹18 Cr | ₹20 Cr | ₹15 Cr | ₹13 Cr | ₹15 Cr |
| Profit After Tax | ₹13 Cr | ₹15 Cr | ₹11 Cr | ₹9.21 Cr | ₹12 Cr |
| Earnings Per Share (Rs) | ₹10.86 | ₹11.79 | ₹9.21 | ₹7.49 | ₹18.87 |
| PAT Margin (%) | 11.78 | 13.52 | 10.46 | 10.86 | 16.81 |
| ROE(%) | 14.47 | 18.49 | 17.29 | 16.44 | 25.02 |
| ROCE(%) | 19.51 | 25.02 | 23.20 | 21.85 | 28.68 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 |
Key Financials |
||
| Market Cap | : | ₹ 106.7 Cr |
| Revenue (TTM) | : | ₹ 103.7 Cr |
| Net Profit(TTM) | : | ₹ 13.1 Cr |
| EPS (TTM) | : | ₹ 10.7 |
| P/E (TTM) | : | 8.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PAR DRUGS AND CHEMICALS | -2.7% | -3.7% | -13.9% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.2% | -2.3% | 5.3% |
| DIVIS LABORATORIES | -1% | -0.9% | -0.9% |
| TORRENT PHARMACEUTICALS | -1.3% | 1.4% | 38.1% |
| CIPLA | -0.1% | 4.8% | -6.9% |
| DR REDDYS LABORATORIES | -2.8% | -0.3% | 1.2% |
| MANKIND PHARMA | -1% | 1.5% | -3.8% |
| LUPIN | -1.1% | -4% | 14.8% |
| ZYDUS LIFESCIENCES | 0.7% | 19% | 16.4% |
PAR DRUGS AND CHEMICALS Revenues
[NSE : PAR]
| Y-o-Y | 5.58 % |
| 5 Yr CAGR | 13.54 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹101 Cr | 5.58 | |
| Mar2024 | ₹96 Cr | -0.11 | |
| Mar2023 | ₹96 Cr | 27.54 | |
| Mar2022 | ₹75 Cr | 23.58 | |
| Mar2021 | ₹61 Cr | - | |
PAR DRUGS AND CHEMICALS Operating Profit
[NSE : PAR]
| Y-o-Y | -14.54 % |
| 5 Yr CAGR | 5.05 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹20 Cr | -14.54 | |
| Mar2024 | ₹23 Cr | 25.33 | |
| Mar2023 | ₹18 Cr | 12.01 | |
| Mar2022 | ₹16 Cr | 1.51 | |
| Mar2021 | ₹16 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -19.07 % |
| 5 Yr CAGR | -7.49 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 19.31% | -19.07 | |
| Mar2024 | 23.86% | 25.45 | |
| Mar2023 | 19.02% | -12.15 | |
| Mar2022 | 21.65% | -17.87 | |
| Mar2021 | 26.36% | - | |
PAR DRUGS AND CHEMICALS Profit After Tax
[NSE : PAR]
| Y-o-Y | -7.88 % |
| 5 Yr CAGR | 3.57 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | -7.88 | |
| Mar2024 | ₹15 Cr | 27.94 | |
| Mar2023 | ₹11 Cr | 23.02 | |
| Mar2022 | ₹9.21 Cr | -20.65 | |
| Mar2021 | ₹12 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -12.87 % |
| 5 Yr CAGR | -8.51 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 11.78 % | -12.87 | |
| Mar2024 | 13.52 % | 29.25 | |
| Mar2023 | 10.46 % | -3.68 | |
| Mar2022 | 10.86 % | -35.40 | |
| Mar2021 | 16.81 % | - | |
PAR DRUGS AND CHEMICALS Earnings Per Share (EPS)
[NSE : PAR]
| Y-o-Y | -7.89 % |
| 5 Yr CAGR | -12.90 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 | -7.89 | |
| Mar2024 | ₹12 | 28.01 | |
| Mar2023 | ₹9.21 | 22.96 | |
| Mar2022 | ₹7.49 | -60.31 | |
| Mar2021 | ₹19 | - | |
PAR DRUGS AND CHEMICALS Return on Capital Employed (ROCE)
[NSE : PAR]
| Y-o-Y | -22.02 % |
| 5 Yr CAGR | -9.18 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 19.51% | -22.02 | |
| Mar2024 | 25.02% | 7.84 | |
| Mar2023 | 23.2% | 6.18 | |
| Mar2022 | 21.85% | -23.81 | |
| Mar2021 | 28.68% | - | |
PAR DRUGS AND CHEMICALS Share Price vs Sensex
| Current Share Price | : | ₹86.7 |
| Current MarketCap | : | ₹ 106.7 Cr |
| Updated EOD on | : | Jun 04,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PAR DRUGS AND CHEMICALS | -2.7% |
-3.7% |
-13.9% |
| SENSEX | -2% |
-3.8% |
-8.6% |
PAR DRUGS AND CHEMICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about PAR DRUGS AND CHEMICALS Financials
How the annual revenues of PAR DRUGS AND CHEMICALS have changed ?
The Revenues of PAR DRUGS AND CHEMICALS have increased by 5.58% YoY .
How the Earnings per Share (EPS) of PAR DRUGS AND CHEMICALS have changed?
The Earnings Per Share (EPS) of PAR DRUGS AND CHEMICALS has decreased by -7.89 % YoY .
Check out Intrinsic Value of Peers of PAR DRUGS AND CHEMICALS
Compare Stock Analytics of Peers of PAR DRUGS AND CHEMICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
